|
1
|
Portera-Cailliau C, Sung CH, Nathans J and
Adler R: Apoptotic photoreceptor cell death in mouse models of
retinitis pigmentosa. Proc Natl Acad Sci USA. 91:974–978. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang GQ, Hao Y and Wong F: Apoptosis:
final common pathway of photoreceptor death in rd, rds and
rhodopsin mutant mice. Neuron. 11:595–605. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen J, Yang X, Dong A, et al: Oxidative
damage is a potential cause of cone cell death in retinitis
pigmentosa. J Cell Physiol. 203:457–464. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Komeima K, Rogers BS, Lu L and Campochiaro
PA: Antioxidants reduce cone cell death in a model of retinitis
pigmentosa. Proc Natl Acad Sci USA. 103:11300–11305. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu DY, Cringle SJ, Su EN and Yu PK:
Intraretinal oxygen levels before and after photoreceptor loss in
the RCS rat. Invest Ophthalmol Vis Sci. 41:3999–4006.
2000.PubMed/NCBI
|
|
6
|
Rotstein NP, Politi LE, German OL and
Girotti R: Protective effect of docosahexaenoic acid on oxidative
stress-induced apoptosis of retina photoreceptors. Invest
Ophthalmol Vis Sci. 44:2252–2259. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Simon HU, Haj-Yehia A and Levi-Schaffer F:
Role of reactive oxygen species (ROS) in apoptosis induction.
Apoptosis. 5:415–418. 2000. View Article : Google Scholar
|
|
8
|
Herrera B, Alvarez AM, Sanchez A, et al:
Reactive oxygen species (ROS) mediates the mitochondrial-dependent
apoptosis induced by transforming growth factor (beta) in fetal
hepatocytes. FASEB J. 15:741–751. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li N, Ragheb K, Lawler G, et al:
Mitochondrial complex I inhibitor rotenone induces apoptosis
through enhancing mitochondrial reactive oxygen species production.
J Biol Chem. 278:8516–8525. 2003. View Article : Google Scholar
|
|
10
|
Palanivel K, Kanimozhi V, Kadalmani B and
Akbarsha MA: Verrucarin A induces apoptosis through ROS-mediated
EGFR/MAPK/Akt signaling pathways in MDA-MB-231 breast cancer cells.
J Cell Biochem. 115:2022–2032. 2014.PubMed/NCBI
|
|
11
|
Szeto HH: Mitochondria-targeted peptide
antioxidants: novel neuroprotective agents. AAPS J. 8:E521–E531.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao K, Zhao GM, Wu D, et al:
Cell-permeable peptide antioxidants targeted to inner mitochondrial
membrane inhibit mitochondrial swelling, oxidative cell death and
reperfusion injury. J Biol Chem. 279:34682–34690. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu D, Soong Y, Zhao GM and Szeto HH: A
highly potent peptide analgesic that protects against
ischemia-reperfusion-induced myocardial stunning. Am J Physiol
Heart Circ Physiol. 283:H783–H791. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cho S, Szeto HH, Kim E, Kim H, Tolhurst AT
and Pinto JT: A novel cell-permeable antioxidant peptide, SS31,
attenuates ischemic brain injury by down-regulating CD36. J Biol
Chem. 282:4634–4642. 2007. View Article : Google Scholar
|
|
15
|
Calkins MJ, Manczak M, Mao P, Shirendeb U
and Reddy PH: Impaired mitochondrial biogenesis, defective axonal
transport of mitochondria, abnormal mitochondrial dynamics and
synaptic degeneration in a mouse model of Alzheimer's disease. Hum
Mol Genet. 20:4515–4529. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Petri S, Kiaei M, Damiano M, et al:
Cell-permeable peptide antioxidants as a novel therapeutic approach
in a mouse model of amyotrophic lateral sclerosis. J Neurochem.
98:1141–1148. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pellicciari C, Bottone MG and Biggiogera
M: Detection of apoptotic cells by annexin V labeling at electron
microscopy. Eur J Histochem. 41:211–216. 1997.PubMed/NCBI
|
|
18
|
Chazotte B: Labeling mitochondria with
JC-1. Cold Spring Harb Protoc. 2011:2011.PubMed/NCBI
|
|
19
|
Soskic V, Groebe K and Schrattenholz A:
Nonenzymatic post-translational protein modifications in ageing.
Exp Gerontol. 43:247–257. 2008. View Article : Google Scholar
|
|
20
|
Schulz JB, Matthews RT, Muqit MM, Browne
SE and Beal MF: Inhibition of neuronal nitric oxide synthase by
7-nitroin-dazole protects against MPTP-induced neurotoxicity in
mice. J Neurochem. 64:936–939. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hartong DT, Berson EL and Dryja TP:
Retinitis pigmentosa. Lancet. 368:1795–1809. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Braun RD, Linsenmeier RA and Goldstick TK:
Oxygen consumption in the inner and outer retina of the cat. Invest
Ophthalmol Vis Sci. 36:542–554. 1995.PubMed/NCBI
|
|
23
|
Maslim J, Valter K, Egensperger R,
Holländer H and Stone J: Tissue oxygen during a critical
developmental period controls the death and survival of
photoreceptors. Invest Ophthalmol Vis Sci. 38:1667–1677.
1997.PubMed/NCBI
|
|
24
|
Sanz MM, Johnson LE, Ahuja S, Ekstrom PA,
Romero J and van Veen T: Significant photoreceptor rescue by
treatment with a combination of antioxidants in an animal model for
retinal degeneration. Neuroscience. 145:1120–1129. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
al-Ubaidi MR, Font RL, Quiambao AB, et al:
Bilateral retinal and brain tumors in transgenic mice expressing
simian virus 40 large T antigen under control of the human
interphotoreceptor retinoid-binding protein promoter. J Cell Biol.
119:1681–1687. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tan E, Ding XQ, Saadi A, Agarwal N, Naash
MI and Al-Ubaidi MR: Expression of cone-photoreceptor-specific
antigens in a cell line derived from retinal tumors in transgenic
mice. Invest Ophthalmol Vis Sci. 45:764–768. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sanvicens N and Cotter TG: Ceramide is the
key mediator of oxidative stress-induced apoptosis in retinal
photoreceptor cells. J Neurochem. 98:1432–1444. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Crawford MJ, Krishnamoorthy RR, Rudick VL,
et al: Bcl-2 overexpression protects photooxidative stress-induced
apoptosis of photoreceptor cells via NF-kappaB preservation.
Biochem Biophys Res Commun. 281:1304–1312. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li A, Zhu X and Craft CM: Retinoic acid
upregulates cone arrestin expression in retinoblastoma cells
through a Cis element in the distal promoter region. Invest
Ophthalmol Vis Sci. 43:1375–1383. 2002.PubMed/NCBI
|
|
30
|
Kyritsis A, Joseph G and Chader GJ:
Effects of butyrate, retinol and retinoic acid on human Y-79
retinoblastoma cells growing in monolayer cultures. J Natl Cancer
Inst. 73:649–654. 1984.PubMed/NCBI
|
|
31
|
Nieminen AL, Byrne AM, Herman B and
Lemasters JJ: Mitochondrial permeability transition in hepatocytes
induced by t-BuOOH: NAD(P)H and reactive oxygen species. Am J
Physiol. 272:C1286–C1294. 1997.PubMed/NCBI
|
|
32
|
Zhao K, Luo G, Giannelli S and Szeto HH:
Mitochondria-targeted peptide prevents mitochondrial depolarization
and apoptosis induced by tert-butyl hydroperoxide in neuronal cell
lines. Biochem Pharmacol. 70:1796–1806. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen M, Liu B, Gao Q, Zhuo Y and Ge J:
Mitochondria-targeted peptide MTP-131 alleviates mitochondrial
dysfunction and oxidative damage in human trabecular meshwork
cells. Invest Ophthalmol Vis Sci. 52:7027–7037. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Veldink JH, Kalmijn S, Groeneveld GJ, et
al: Intake of polyunsaturated fatty acids and vitamin E reduces the
risk of developing amyotrophic lateral sclerosis. J Neurol
Neurosurg Psychiatry. 78:367–371. 2007. View Article : Google Scholar
|
|
35
|
Sikorska M, Lanthier P, Miller H, et al:
Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively
blocks ongoing neurodegeneration in the mouse
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use
as an adjuvant treatment in Parkinson's disease. Neurobiol Aging.
35:2329–2346. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Maczurek A, Hager K, Kenklies M, et al:
Lipoic acid as an anti-inflammatory and neuroprotective treatment
for Alzheimer's disease. Adv Drug Deliv Rev. 60:1463–1470. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fielder AR: A randomized trial of vitamin
A and vitamin E supplementation for retinitis pigmentosa. Arch
Ophthalmol. 111:1463Author Reply 1463–1466. 1993.PubMed/NCBI
|
|
38
|
Berson EL, Rosner B, Sandberg MA, et al:
Further evaluation of docosahexaenoic acid in patients with
retinitis pigmentosa receiving vitamin A treatment: subgroup
analyses. Arch Ophthalmol. 122:1306–1314. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Miller ER III, Pastor-Barriuso R, Dalal D,
Riemersma RA, Appel LJ and Guallar E: Meta-analysis: high-dosage
vitamin E supplementation may increase all-cause mortality. Ann
Intern Med. 142:37–46. 2005. View Article : Google Scholar
|
|
40
|
Jauslin ML, Meier T, Smith RA and Murphy
MP: Mitochondria-targeted antioxidants protect Friedreich Ataxia
fibroblasts from endogenous oxidative stress more effectively than
untargeted antioxidants. FASEB J. 17:1972–1974. 2003.PubMed/NCBI
|
|
41
|
Kelso GF, Porteous CM, Coulter CV, et al:
Selective targeting of a redox-active ubiquinone to mitochondria
within cells: antioxidant and antiapoptotic properties. J Biol
Chem. 276:4588–4596. 2001. View Article : Google Scholar
|
|
42
|
Beal MF and Matthews RT: Coenzyme Q10 in
the central nervous system and its potential usefulness in the
treatment of neurode-generative diseases. Mol Aspects Med.
18(Suppl): 169–179. 1997. View Article : Google Scholar
|
|
43
|
Li J, Chen X, Xiao W, et al:
Mitochondria-targeted antioxidant peptide SS31 attenuates high
glucose-induced injury on human retinal endothelial cells. Biochem
Biophys Res Commun. 404:349–356. 2011. View Article : Google Scholar
|
|
44
|
Huang J, Li X, Li M, et al:
Mitochondria-targeted antioxidant peptide SS31 protects the retinas
of diabetic rats. Curr Mol Med. 13:935–945. 2013. View Article : Google Scholar : PubMed/NCBI
|
